Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norah L Henry
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
490 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Nacional de Enfermedades Neoplasicas
Lima, Peru
- Kingman Regional Medical Center
Kingman, Arizona, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Ais Cancer Center at San Joaquin Community Hospital
Bakersfield, California, United States
- Marshall Cancer Center
Cameron Park, California, United States
- Mercy Cancer Center �� Carmichael
Carmichael, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Mercy Cancer Center - Elk Grove
Elk Grove, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Fresno Cancer Center
Fresno, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Kaiser Permanente- Marshall Medical Offices
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Mercy Cancer Center - Rocklin
Rocklin, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- the Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, United States
- Kaiser Permanente Downtown Commons
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Mercy Cancer Center - Sacramento
Sacramento, California, United States
- South Sacramento Cancer Center
Sacramento, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Kaiser Permanente San Leandro
San Leandro, California, United States
- Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, United States
- Kaiser San Rafael-Gallinas
San Rafael, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Mar 2023
- Primary completion
- 1 May 2027
- Completion
- 1 May 2028
- Last update posted
- 2 Apr 2026
- Registered enrollment
- 565
- Registry id
- NCT05568472
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.